Home › Ovarian Cancer › Illinois › Arlington Heights
Ovarian Cancer clinical trials in Arlington Heights, IL
5 studies for Ovarian Cancer are looking for participants at sites in and around Arlington Heights (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Advocate Good Shepherd Hospital, Barrington · 9 mi away
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Illinois Cancer Specialists, Arlington Heights
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RecruitingPhase 3
- Illinois Cancer Specialists (ICS) ( Site 8009), Arlington Heights
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- Advocate Good Shepherd Hospital, Barrington · 9 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Advocate Good Shepherd Hospital, Barrington · 9 mi away
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Arlington Heights
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer12 studies
- Lung Cancer9 studies
- Breast Cancer7 studies
- Heart Failure7 studies
- Metastatic Cancer6 studies
- Ulcerative Colitis6 studies
- Colon Cancer6 studies
- Obesity5 studies
- Overweight5 studies
- Prostate Cancer3 studies
- Skin Conditions3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.